Nifty

:

25461.00

Sensex

:

83432.89

55.70 (0.22%)
193.42 (0.23%)

Login

Nifty
Sensex

:
:

25461.00
83432.89

55.70 (0.22%)
193.42 (0.23%)

Natco Pharma Ltd.

Pharmaceuticals & Drugs - Global

Rating :

59/99

BSE: 524816 | NSE: NATCOPHARM

Watchlist

NSE BSE

998.60

04-Jul-2025

Open
High
Low
Previous Close

976.2
1002.9
965.7
973.60

Volume
Traded Value (lacs)
52 Week High
52 Week Low

2569046
2532818163.1
1639
726.8

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

17,880.54
9.48
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

15,977.64
0.60%
2.35

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

17.09
15.86
27.16

EBITDA CAGR (%)

10 Years
5 Years
3 Years

23.43
24.62
46.06

PAT CAGR (%)

10 Years
5 Years
3 Years

26.28
24.68
101.38

P:E (Median)

8 Years
5 Years
3 Years

22.45
26.13
15.75

P:BV (Average)

8 Years
5 Years
3 Years

3.69
3.26
2.84

EV:EBITDA (Average)

8 Years
5 Years
3 Years

16.92
18.13
12.25

Earnings Forecasts:

(Updated: 06-06-2025)

Description 2024 2025 2026 2027
Adj EPS 77.34 105.26 109.76 38.58
P/E Ratio 12.91 9.49 9.10 25.88
Revenue 3999 4430 5069 3449
EBITDA 1751 2338 788
Net Income 1388 1885 1917 693
ROA 22.1 21.5 6.9
P/B Ratio 3.20 1.96 1.84
ROE 25.88 24.87 8.25
FCFF 913 1481 901
FCFF Yield 6.33 10.27 6.25
Net Debt -1025
BVPS 312.23 510.05 544.03

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 1,157.40 964.80 19.96% 407.60 625.30 -34.82% 1,292.60 930.50 38.91% 1,236.90 1,048.30 17.99%
Expenses 596.20 512.10 16.42% 378.20 387.00 -2.27% 501.90 488.20 2.81% 473.90 544.60 -12.98%
EBITDA 561.20 452.70 23.97% 29.40 238.30 -87.66% 790.70 442.30 78.77% 763.00 503.70 51.48%
EBIDTM 48.49% 46.92% 7.21% 38.11% 61.17% 47.53% 61.69% 48.05%
Other Income 62.10 35.90 72.98% 168.00 29.50 469.49% 51.40 24.70 108.10% 39.80 14.60 172.60%
Interest 8.80 4.50 95.56% 3.40 3.80 -10.53% 3.00 3.00 0.00% 4.40 3.20 37.50%
Depreciation 93.70 51.60 81.59% 43.70 40.40 8.17% 42.20 40.00 5.50% 40.40 39.90 1.25%
PBT 520.80 432.50 20.42% 150.30 223.60 -32.78% 796.90 424.00 87.95% 758.00 475.20 59.51%
Tax 92.70 83.40 11.15% 25.40 31.60 -19.62% 135.80 63.80 112.85% 121.70 69.90 74.11%
PAT 428.10 349.10 22.63% 124.90 192.00 -34.95% 661.10 360.20 83.54% 636.30 405.30 56.99%
PATM 36.99% 36.18% 30.64% 30.71% 51.15% 38.71% 51.44% 38.66%
EPS 23.90 19.49 22.63% 6.97 10.72 -34.98% 36.91 20.11 83.54% 35.53 22.63 57.00%

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 1,221.00 1,068.30 14.29% 474.80 758.60 -37.41% 1,371.10 1,031.40 32.94% 1,362.60 1,140.50 19.47%
Expenses 672.90 571.00 17.85% 436.00 490.50 -11.11% 566.80 573.40 -1.15% 557.80 612.50 -8.93%
EBITDA 548.10 497.30 10.22% 38.80 268.10 -85.53% 804.30 458.00 75.61% 804.80 528.00 52.42%
EBIDTM 44.89% 46.55% 8.17% 35.34% 58.66% 44.41% 59.06% 46.30%
Other Income 66.30 42.00 57.86% 176.30 37.00 376.49% 63.80 29.40 117.01% 48.10 19.70 144.16%
Interest 10.20 6.20 64.52% 4.40 4.60 -4.35% 4.10 4.20 -2.38% 5.20 4.20 23.81%
Depreciation 98.30 55.50 77.12% 47.00 44.20 6.33% 45.80 43.60 5.05% 44.10 43.50 1.38%
PBT 505.90 477.60 5.93% 163.70 256.30 -36.13% 818.20 439.60 86.12% 803.60 500.00 60.72%
Tax 99.90 91.30 9.42% 31.30 43.60 -28.21% 141.70 70.60 100.71% 135.10 79.70 69.51%
PAT 406.00 386.30 5.10% 132.40 212.70 -37.75% 676.50 369.00 83.33% 668.50 420.30 59.05%
PATM 33.25% 36.16% 27.89% 28.04% 49.34% 35.78% 49.06% 36.85%
EPS 22.72 21.58 5.28% 7.43 11.88 -37.46% 37.84 20.61 83.60% 37.35 23.48 59.07%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 4,094.50 3,568.90 2,351.00 1,767.80 1,653.50 1,790.20 1,986.30 2,091.30 1,958.00 1,021.40 715.55 Net Sales Growth 14.73% 51.80% 32.99% 6.91% -7.64% -9.87% -5.02% 6.81% 91.70% 42.74% Cost Of Goods Sold 593.30 525.80 485.60 502.10 472.30 369.80 317.60 388.50 572.80 256.30 170.70 Gross Profit 3,501.20 3,043.10 1,865.40 1,265.70 1,181.20 1,420.40 1,668.70 1,702.80 1,385.20 765.10 544.85 GP Margin 85.51% 85.27% 79.34% 71.60% 71.44% 79.34% 84.01% 81.42% 70.75% 74.91% 76.14% Total Expenditure 1,950.20 1,931.90 1,530.20 1,554.80 1,238.30 1,212.20 1,169.80 1,162.90 1,266.00 740.70 486.99 Power & Fuel Cost - 88.90 81.90 76.40 59.40 62.40 59.60 56.10 50.50 43.70 40.49 % Of Sales - 2.49% 3.48% 4.32% 3.59% 3.49% 3.00% 2.68% 2.58% 4.28% 5.66% Employee Cost - 454.90 425.70 410.10 380.00 356.10 340.20 312.20 232.10 171.90 116.19 % Of Sales - 12.75% 18.11% 23.20% 22.98% 19.89% 17.13% 14.93% 11.85% 16.83% 16.24% Manufacturing Exp. - 341.70 269.90 340.80 160.50 230.40 257.50 175.10 134.20 100.60 65.41 % Of Sales - 9.57% 11.48% 19.28% 9.71% 12.87% 12.96% 8.37% 6.85% 9.85% 9.14% General & Admin Exp. - 253.10 155.70 122.50 92.60 111.20 103.90 96.00 78.30 56.90 48.57 % Of Sales - 7.09% 6.62% 6.93% 5.60% 6.21% 5.23% 4.59% 4.00% 5.57% 6.79% Selling & Distn. Exp. - 117.40 59.50 27.00 29.20 22.60 33.50 98.00 128.80 88.40 34.29 % Of Sales - 3.29% 2.53% 1.53% 1.77% 1.26% 1.69% 4.69% 6.58% 8.65% 4.79% Miscellaneous Exp. - 150.10 51.90 75.90 44.30 59.70 57.50 37.00 69.30 22.90 34.29 % Of Sales - 4.21% 2.21% 4.29% 2.68% 3.33% 2.89% 1.77% 3.54% 2.24% 1.58% EBITDA 2,144.30 1,637.00 820.80 213.00 415.20 578.00 816.50 928.40 692.00 280.70 228.56 EBITDA Margin 52.37% 45.87% 34.91% 12.05% 25.11% 32.29% 41.11% 44.39% 35.34% 27.48% 31.94% Other Income 321.30 104.70 109.40 94.60 103.50 123.80 129.80 39.40 13.20 12.90 13.57 Interest 19.60 14.50 8.60 13.30 11.30 20.60 18.80 14.70 17.50 21.90 30.13 Depreciation 220.00 171.90 150.90 138.40 115.20 98.10 80.10 65.50 53.60 50.20 42.46 PBT 2,226.00 1,555.30 770.70 155.90 392.20 583.10 847.40 887.60 634.10 221.50 169.54 Tax 375.60 248.70 133.60 16.80 82.70 108.60 180.30 189.40 139.30 45.00 1.48 Tax Rate 16.87% 15.99% 17.33% 10.78% 21.09% 18.62% 21.28% 21.34% 21.97% 20.32% 0.96% PAT 1,850.40 1,306.60 637.10 139.10 309.50 474.50 667.10 698.20 494.80 176.50 152.93 PAT before Minority Interest 1,850.40 1,306.60 637.10 139.10 309.50 474.50 667.10 698.20 494.80 176.50 152.93 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 45.19% 36.61% 27.10% 7.87% 18.72% 26.51% 33.59% 33.39% 25.27% 17.28% 21.37% PAT Growth 41.62% 105.09% 358.02% -55.06% -34.77% -28.87% -4.45% 41.11% 180.34% 15.41% EPS 103.32 72.95 35.57 7.77 17.28 26.49 37.25 38.98 27.63 9.85 8.54

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 4,429.50 3,998.80 2,707.10 1,944.80 2,052.10 1,915.00 2,094.50 2,184.80 2,020.20 1,141.30 825.28 Net Sales Growth 10.77% 47.72% 39.20% -5.23% 7.16% -8.57% -4.13% 8.15% 77.01% 38.29% Cost Of Goods Sold 689.80 667.90 583.20 528.40 483.70 354.40 332.70 411.10 599.10 341.10 242.37 Gross Profit 3,739.70 3,330.90 2,123.90 1,416.40 1,568.40 1,560.60 1,761.80 1,773.70 1,421.10 800.20 582.90 GP Margin 84.43% 83.30% 78.46% 72.83% 76.43% 81.49% 84.12% 81.18% 70.34% 70.11% 70.63% Total Expenditure 2,233.50 2,247.40 1,795.40 1,681.30 1,448.30 1,332.40 1,299.70 1,256.40 1,336.80 868.70 611.90 Power & Fuel Cost - 88.90 81.90 76.40 61.10 62.40 59.60 56.20 50.50 43.70 43.24 % Of Sales - 2.22% 3.03% 3.93% 2.98% 3.26% 2.85% 2.57% 2.50% 3.83% 5.24% Employee Cost - 525.00 486.70 444.80 414.90 375.00 355.90 325.60 243.20 189.60 136.92 % Of Sales - 13.13% 17.98% 22.87% 20.22% 19.58% 16.99% 14.90% 12.04% 16.61% 16.59% Manufacturing Exp. - 368.40 279.60 353.60 165.70 243.30 276.40 182.60 141.20 105.20 73.04 % Of Sales - 9.21% 10.33% 18.18% 8.07% 12.70% 13.20% 8.36% 6.99% 9.22% 8.85% General & Admin Exp. - 313.00 208.80 152.80 242.90 132.60 126.40 105.50 88.10 73.40 63.66 % Of Sales - 7.83% 7.71% 7.86% 11.84% 6.92% 6.03% 4.83% 4.36% 6.43% 7.71% Selling & Distn. Exp. - 153.00 96.10 43.70 34.40 98.10 90.00 136.90 143.20 91.60 37.36 % Of Sales - 3.83% 3.55% 2.25% 1.68% 5.12% 4.30% 6.27% 7.09% 8.03% 4.53% Miscellaneous Exp. - 131.20 59.10 81.60 45.60 66.60 58.70 38.50 71.50 24.10 37.36 % Of Sales - 3.28% 2.18% 4.20% 2.22% 3.48% 2.80% 1.76% 3.54% 2.11% 1.86% EBITDA 2,196.00 1,751.40 911.70 263.50 603.80 582.60 794.80 928.40 683.40 272.60 213.38 EBITDA Margin 49.58% 43.80% 33.68% 13.55% 29.42% 30.42% 37.95% 42.49% 33.83% 23.89% 25.86% Other Income 354.50 128.10 128.50 99.00 106.00 107.40 130.20 40.40 13.90 9.90 14.91 Interest 23.90 19.20 14.50 17.70 13.30 21.50 19.30 15.40 18.50 22.90 31.68 Depreciation 235.20 186.80 163.80 142.60 116.90 99.80 81.00 66.20 54.40 51.00 47.27 PBT 2,291.40 1,673.50 861.90 202.20 579.60 568.70 824.70 887.20 624.40 208.60 149.34 Tax 408.00 285.20 146.60 32.20 137.20 110.60 182.30 192.00 139.50 52.80 3.95 Tax Rate 17.81% 17.04% 17.01% 15.92% 23.67% 19.45% 22.11% 21.64% 22.34% 25.31% 2.94% PAT 1,883.40 1,388.30 715.30 170.00 440.90 460.80 644.40 696.20 486.00 157.10 134.62 PAT before Minority Interest 1,885.40 1,388.30 715.30 170.00 442.40 458.10 642.40 695.20 484.90 155.80 130.27 Minority Interest 2.00 0.00 0.00 0.00 -1.50 2.70 2.00 1.00 1.10 1.30 4.35 PAT Margin 42.52% 34.72% 26.42% 8.74% 21.49% 24.06% 30.77% 31.87% 24.06% 13.77% 16.31% PAT Growth 35.66% 94.09% 320.76% -61.44% -4.32% -28.49% -7.44% 43.25% 209.36% 16.70% EPS 105.16 77.52 39.94 9.49 24.62 25.73 35.98 38.87 27.14 8.77 7.52

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 5,592.30 4,702.00 4,191.90 4,091.10 3,869.50 3,563.20 3,125.40 1,699.70 1,336.30 878.99 Share Capital 35.80 36.50 36.50 36.50 36.40 36.50 36.90 34.90 34.80 33.23 Total Reserves 5,556.50 4,665.50 4,152.00 4,037.00 3,809.50 3,495.80 3,064.30 1,649.40 1,291.80 845.76 Non-Current Liabilities 69.00 116.90 134.90 142.90 117.50 83.10 47.00 37.70 27.90 117.53 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 96.28 Unsecured Loans 0.00 0.00 0.00 0.00 0.90 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 70.90 85.30 95.70 99.60 90.20 71.00 32.40 21.90 12.50 9.19 Current Liabilities 885.60 569.00 651.20 518.50 659.70 709.80 563.80 609.70 478.50 398.31 Trade Payables 183.30 182.40 141.20 139.50 234.20 201.80 245.40 251.40 270.10 115.34 Other Current Liabilities 204.70 201.40 104.00 111.10 93.40 108.50 131.70 122.80 110.90 113.32 Short Term Borrowings 363.20 159.90 389.00 255.10 313.10 384.50 173.00 220.60 96.00 168.54 Short Term Provisions 134.40 25.30 17.00 12.80 19.00 15.00 13.70 14.90 1.50 1.11 Total Liabilities 6,546.90 5,387.90 4,978.00 4,752.50 4,646.70 4,356.10 3,736.20 2,347.10 1,842.70 1,394.83 Net Block 2,286.70 2,233.80 2,174.20 2,005.90 1,574.50 1,214.90 1,015.30 829.00 705.60 572.74 Gross Block 3,359.50 3,157.10 2,977.80 2,678.30 2,133.70 1,678.20 1,399.60 1,151.00 975.90 783.12 Accumulated Depreciation 1,072.80 923.30 803.60 672.40 559.20 463.30 384.30 322.00 270.30 210.39 Non Current Assets 3,136.50 2,893.20 2,810.30 2,584.00 2,406.80 2,088.70 1,682.00 1,312.00 1,051.80 950.65 Capital Work in Progress 133.90 62.80 128.70 223.40 517.80 637.50 480.00 336.20 211.90 100.77 Non Current Investment 577.80 517.60 430.40 294.90 186.10 117.60 101.30 85.90 71.70 131.15 Long Term Loans & Adv. 111.50 78.80 72.40 55.60 124.30 110.40 83.10 60.40 62.00 142.47 Other Non Current Assets 26.60 0.20 4.60 4.20 4.10 8.30 2.30 0.50 0.60 3.52 Current Assets 3,410.40 2,494.70 2,167.70 2,168.50 2,239.90 2,267.40 2,054.20 1,035.10 790.90 444.18 Current Investments 163.90 139.90 119.60 42.10 5.00 126.80 48.30 8.90 22.10 0.12 Inventories 596.90 616.00 697.70 769.20 524.40 508.40 425.80 336.90 351.90 198.35 Sundry Debtors 1,076.60 793.10 575.60 399.80 536.70 491.60 606.00 468.90 255.80 188.96 Cash & Bank 864.90 412.00 100.90 262.80 54.10 262.70 172.10 25.10 40.20 7.19 Other Current Assets 708.10 57.60 78.10 95.20 1,119.70 877.90 802.00 195.30 120.90 49.57 Short Term Loans & Adv. 622.00 476.10 595.80 599.40 1,025.90 769.50 748.80 169.60 95.50 43.99 Net Current Assets 2,524.80 1,925.70 1,516.50 1,650.00 1,580.20 1,557.60 1,490.40 425.40 312.40 45.87 Total Assets 6,546.90 5,387.90 4,978.00 4,752.50 4,646.70 4,356.10 3,736.20 2,347.10 1,842.70 1,394.83

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 5,853.10 4,873.80 4,263.60 4,121.60 3,773.50 3,489.00 3,072.20 1,649.30 1,295.70 846.05 Share Capital 35.80 36.50 36.50 36.50 36.40 36.50 36.90 34.90 34.80 33.23 Total Reserves 5,817.30 4,837.30 4,223.70 4,067.60 3,713.60 3,421.70 3,011.40 1,599.00 1,251.20 812.82 Non-Current Liabilities 61.00 100.50 135.10 142.90 117.80 83.40 47.10 37.70 28.00 119.23 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 94.03 Unsecured Loans 0.00 0.00 0.00 0.00 0.90 0.00 0.00 0.00 0.00 2.99 Long Term Provisions 70.90 85.30 95.70 99.60 90.20 71.00 32.40 21.90 12.50 9.50 Current Liabilities 972.80 683.10 710.40 525.60 685.30 728.70 592.00 626.50 493.10 413.74 Trade Payables 235.50 263.80 161.80 146.20 255.40 217.00 269.10 262.70 275.60 125.30 Other Current Liabilities 238.90 227.30 126.70 99.50 95.90 109.80 133.40 127.10 114.20 118.56 Short Term Borrowings 363.20 165.00 404.00 265.80 315.00 386.30 173.20 221.60 98.40 168.54 Short Term Provisions 135.20 27.00 17.90 14.10 19.00 15.60 16.30 15.10 4.90 1.33 Total Liabilities 6,886.90 5,657.40 5,109.10 4,791.90 4,587.80 4,303.10 3,715.10 2,317.60 1,821.70 1,384.05 Net Block 2,490.80 2,426.90 2,311.80 2,023.20 1,584.40 1,227.20 1,018.60 833.00 710.10 709.97 Gross Block 3,603.20 3,375.10 3,126.90 2,702.10 2,148.70 1,694.50 1,407.60 1,158.70 983.30 939.98 Accumulated Depreciation 1,112.40 948.20 815.10 678.90 564.30 467.30 389.00 325.70 273.20 225.82 Non Current Assets 2,863.40 2,657.10 2,622.40 2,447.10 2,262.20 1,955.90 1,584.40 1,230.30 984.70 901.08 Capital Work in Progress 137.30 64.30 129.50 223.40 518.00 637.60 480.00 336.30 211.80 128.96 Non Current Investment 95.90 87.30 104.40 151.90 83.60 19.90 8.10 0.10 0.10 1.57 Long Term Loans & Adv. 112.70 78.30 72.00 44.30 72.00 62.80 75.40 60.40 62.10 57.03 Other Non Current Assets 26.70 0.30 4.70 4.30 4.20 8.40 2.30 0.50 0.60 3.54 Current Assets 4,023.50 3,000.30 2,486.70 2,344.80 2,325.60 2,347.20 2,130.70 1,087.30 837.00 482.97 Current Investments 443.50 305.00 203.70 151.80 28.70 148.70 68.40 32.10 22.10 0.12 Inventories 700.50 742.90 762.00 798.20 558.00 529.00 438.40 348.90 357.30 220.00 Sundry Debtors 1,188.90 856.10 620.60 412.90 551.30 506.20 637.50 475.20 261.60 192.43 Cash & Bank 952.90 546.30 206.10 283.50 66.00 279.50 183.70 35.80 45.20 13.36 Other Current Assets 737.70 64.40 88.10 94.70 1,121.60 883.80 802.70 195.30 150.80 57.06 Short Term Loans & Adv. 638.20 485.60 606.20 603.70 1,030.00 776.40 749.50 169.50 125.40 40.97 Net Current Assets 3,050.70 2,317.20 1,776.30 1,819.20 1,640.30 1,618.50 1,538.70 460.80 343.90 69.23 Total Assets 6,886.90 5,657.40 5,109.10 4,791.90 4,587.80 4,303.10 3,715.10 2,317.60 1,821.70 1,384.05

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 1,196.40 784.40 57.70 183.50 422.50 698.80 476.40 329.80 189.90 124.55 PBT 1,555.30 770.70 155.90 392.20 583.10 847.40 887.60 634.10 221.50 154.41 Adjustment 150.90 85.40 118.50 58.40 45.20 12.10 74.40 99.80 81.70 62.73 Changes in Working Capital -257.80 76.70 -184.20 -190.20 -100.70 14.20 -281.20 -281.70 -68.50 -72.49 Cash after chg. in Working capital 1,448.40 932.80 90.20 260.40 527.60 873.70 680.80 452.20 234.70 144.64 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -252.00 -148.40 -32.50 -76.90 -105.10 -174.90 -204.40 -122.40 -44.80 -20.09 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -960.50 -436.60 -92.50 -3.20 -165.00 -645.20 -1,131.10 -290.60 -249.30 -147.95 Net Fixed Assets -273.50 -113.40 -204.80 -250.20 -335.80 -436.10 -392.40 -299.40 -303.91 -100.13 Net Investments -84.20 -107.50 -213.00 -145.90 53.30 -94.80 -54.80 -1.00 37.47 -42.37 Others -602.80 -215.70 325.30 392.90 117.50 -114.30 -683.90 9.80 17.14 -5.45 Cash from Financing Activity -237.30 -346.80 35.60 -183.10 -261.10 -52.20 652.00 -45.60 151.40 22.80 Net Cash Inflow / Outflow -1.40 1.00 0.80 -2.80 -3.60 1.40 -2.70 -6.40 92.00 -0.59 Opening Cash & Equivalents 6.90 5.90 5.10 7.90 11.50 10.10 12.80 19.20 -170.00 6.86 Closing Cash & Equivalent 5.50 6.90 5.90 5.10 7.90 11.50 10.10 12.80 -76.80 6.27

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 1,211.60 849.10 46.50 298.80 417.30 668.80 463.60 345.80 112.20 92.67 PBT 1,673.50 861.90 202.20 579.60 568.70 824.70 887.20 624.40 208.60 134.22 Adjustment 133.80 102.00 123.90 62.10 54.00 14.30 75.60 100.20 90.50 68.14 Changes in Working Capital -309.40 62.70 -231.40 -212.90 -97.60 8.60 -294.60 -253.00 -140.70 -85.96 Cash after chg. in Working capital 1,497.90 1,026.60 94.70 428.80 525.10 847.60 668.20 471.60 158.40 116.41 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -286.30 -177.50 -48.20 -130.00 -107.80 -178.80 -204.60 -125.80 -46.20 -23.74 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -1,032.70 -477.10 -5.30 -103.30 -167.00 -612.20 -1,115.50 -299.40 -175.50 -114.75 Net Fixed Assets -273.50 -113.40 -204.80 -250.20 -335.80 -436.10 -392.40 -299.40 -303.91 -100.13 Net Investments -84.20 -107.50 -213.00 -145.90 53.30 -94.80 -54.80 -1.00 37.47 -42.37 Others -675.00 -256.20 412.50 292.80 115.50 -81.30 -668.30 1.00 90.94 27.75 Cash from Financing Activity -246.90 -363.00 34.80 -185.70 -250.80 -50.90 650.90 -47.70 154.00 29.07 Net Cash Inflow / Outflow -68.00 9.00 76.00 9.80 -0.50 5.70 -1.00 -1.30 90.70 6.99 Opening Cash & Equivalents 131.90 111.10 25.80 19.80 28.30 21.70 23.50 24.20 -164.10 10.22 Closing Cash & Equivalent 70.40 131.90 111.10 25.80 19.80 28.30 21.70 23.50 -74.20 12.44

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 312.42 257.64 229.51 223.21 211.31 193.55 168.09 96.52 76.24 52.90 ROA 21.90% 12.29% 2.86% 6.59% 10.54% 16.49% 22.95% 23.62% 10.90% 11.90% ROE 25.38% 14.33% 3.37% 7.82% 12.86% 20.11% 29.18% 32.87% 16.00% 18.97% ROCE 29.02% 16.51% 3.79% 9.46% 14.85% 23.91% 34.58% 38.71% 18.48% 17.10% Fixed Asset Turnover 1.15 0.78 0.65 0.70 0.99 1.41 1.65 1.88 1.20 0.99 Receivable days 90.80 104.18 96.61 101.41 99.38 92.04 93.04 66.04 76.63 76.52 Inventory Days 58.90 100.00 145.29 140.07 99.81 78.34 66.02 62.77 94.81 90.45 Payable days 126.93 121.62 102.03 144.40 66.65 73.69 81.82 79.78 95.04 82.23 Cash Conversion Cycle 22.77 82.56 139.87 97.08 132.54 96.69 77.23 49.02 76.39 84.74 Total Debt/Equity 0.06 0.03 0.09 0.06 0.08 0.11 0.06 0.13 0.08 0.35 Interest Cover 108.26 90.62 12.72 35.71 29.31 46.07 61.38 37.23 11.11 6.12

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 326.99 267.06 233.44 224.88 206.04 189.49 165.22 93.63 73.91 50.91 ROA 22.13% 13.29% 3.43% 9.43% 10.30% 16.02% 23.05% 23.43% 9.72% 10.10% ROE 25.88% 15.66% 4.06% 11.27% 12.71% 19.75% 29.70% 33.21% 14.62% 16.57% ROCE 30.08% 18.06% 4.86% 13.99% 14.82% 23.71% 35.28% 39.21% 18.04% 15.62% Fixed Asset Turnover 1.24 0.89 0.76 0.86 1.07 1.47 1.72 1.93 1.23 0.95 Receivable days 86.16 93.53 85.10 84.44 93.77 91.36 92.22 65.12 70.27 67.76 Inventory Days 60.81 95.32 128.47 118.77 96.38 77.28 65.25 62.41 89.35 87.33 Payable days 136.43 133.18 106.38 151.52 65.96 72.53 81.42 78.30 85.42 73.36 Cash Conversion Cycle 10.54 55.67 107.20 51.68 124.19 96.11 76.05 49.23 74.21 81.73 Total Debt/Equity 0.06 0.03 0.09 0.06 0.08 0.11 0.06 0.14 0.09 0.37 Interest Cover 88.16 60.44 12.42 44.58 27.45 43.73 58.61 34.75 10.11 5.24

Top Investors:

belgrave investment fund

life insurance corporation of india ltd

tata mutual fund- tata equity p/e fund

akash bhanshali

investor education and protection fund (iepf)

Annual Reports:

News Update:

USFDA concludes inspection at Natco Pharma’s Kothur pharma division
20th Jun 2025, 10:20 AM

On conclusion of the inspection, the Company received seven observations in the Form-483
Read More
USFDA concludes inspection at Natco Pharma’s Hyderabad API manufacturing plant
13th Jun 2025, 16:44 PM

On conclusion of the inspection, the Company received 1 observation in the Form 483
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback